Experiences with
Regorafenib3 public posts
HCC (hepato cellular carcinoma ) patient survey
Have you been diagnosed with HCC and are currently on oral systemic therapy drug treatment for liver cancer (for example, sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, or cabozantinib)? If so, we’d like to ask for your help.
Do you have liver cancer?
Urgent help needed
We are looking for one or two patients who have liver cancer and are currently being treated by systemic drug therapy (e.g. regorafenib, nivolu¬mab, lenvatinib, pembrolizumab, and cabozantinib) to help us with the design of a patient survey.
Want to take advantage of all our features? Just log in!
or